These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 10438241

  • 1. History and nomenclature of alpha1-adrenoceptors.
    Langer SZ.
    Eur Urol; 1999; 36 Suppl 1():2-6. PubMed ID: 10438241
    [Abstract] [Full Text] [Related]

  • 2. History and nomenclature of alpha1-adrenoceptors.
    Langer SZ.
    Eur Urol; 1999; 36 Suppl 1():2-6. PubMed ID: 10393465
    [Abstract] [Full Text] [Related]

  • 3. Nomenclature and state of the art on alpha1-adrenoceptors.
    Langer SZ.
    Eur Urol; 1998; 33 Suppl 2():2-6. PubMed ID: 9556189
    [Abstract] [Full Text] [Related]

  • 4. [The role of alpha1-adrenoceptor subtypes in benign prostatic hyperplasia-from bed to bench].
    Kojima Y, Hayase M, Imura M, Okada S, Kubota Y, Sasaki S, Hayashi Y, Kohri K.
    Hinyokika Kiyo; 2008 Jun; 54(6):457-62. PubMed ID: 18634446
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification.
    Ford AP, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD, Clarke DE.
    Br J Pharmacol; 1997 Jul; 121(6):1127-35. PubMed ID: 9249248
    [Abstract] [Full Text] [Related]

  • 6. Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties.
    Uberti MA, Hall RA, Minneman KP.
    Mol Pharmacol; 2003 Dec; 64(6):1379-90. PubMed ID: 14645668
    [Abstract] [Full Text] [Related]

  • 7. Localization and expression of the alpha1A-1, alpha1B and alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate.
    Walden PD, Gerardi C, Lepor H.
    J Urol; 1999 Feb; 161(2):635-40. PubMed ID: 9915474
    [Abstract] [Full Text] [Related]

  • 8. alpha1- and alpha2-adrenoceptors in BPH.
    Takeda M, Hatano A, Arai K, Obara K, Tsutsui T, Takahashi K.
    Eur Urol; 1999 Feb; 36 Suppl 1():31-4; discussion 65. PubMed ID: 10393470
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of alpha1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA.
    Nakamura S, Taniguchi T, Suzuki F, Akagi Y, Muramatsu I.
    Br J Pharmacol; 1999 Jul; 127(6):1367-74. PubMed ID: 10455286
    [Abstract] [Full Text] [Related]

  • 10. Adrenoceptor pharmacology: urogenital applications.
    Ruffolo RR, Hieble JP.
    Eur Urol; 1999 Jul; 36 Suppl 1():17-22. PubMed ID: 10393468
    [Abstract] [Full Text] [Related]

  • 11. RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification.
    Ford AP, Arredondo NF, Blue DR, Bonhaus DW, Jasper J, Kava MS, Lesnick J, Pfister JR, Shieh IA, Vimont RL, Williams TJ, McNeal JE, Stamey TA, Clarke DE.
    Mol Pharmacol; 1996 Feb; 49(2):209-15. PubMed ID: 8632751
    [Abstract] [Full Text] [Related]

  • 12. Expression of alpha1-adrenoceptor subtype mRNA as a predictor of the efficacy of subtype selective alpha1-adrenoceptor antagonists in the management of benign prostatic hyperplasia.
    Kojima Y, Sasaki S, Kubota Y, Hayase M, Hayashi Y, Shinoura H, Tsujimoto G, Kohri K.
    J Urol; 2008 Mar; 179(3):1040-6. PubMed ID: 18206918
    [Abstract] [Full Text] [Related]

  • 13. Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia.
    Kojima Y, Sasaki S, Kubota Y, Imura M, Oda N, Kiniwa M, Hayashi Y, Kohri K.
    J Urol; 2011 Oct; 186(4):1530-6. PubMed ID: 21855934
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological characterization of alpha-adrenoceptors that mediate contraction in splenic artery strips from the pig.
    Barbieri A, Santagostino-Barbone MG, Zonta F, Lucchelli A.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):654-61. PubMed ID: 9686942
    [Abstract] [Full Text] [Related]

  • 15. Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists.
    Andersson KE.
    World J Urol; 2002 Apr; 19(6):390-6. PubMed ID: 12022707
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alpha1 adrenergic receptor blockade in the male lower urinary tract and other body systems.
    Andersson KE.
    Scand J Urol Nephrol Suppl; 1995 Apr; 168():13-9. PubMed ID: 7541547
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 8-NH2-boldine, an antagonist of alpha1A and alpha1B adrenoceptors without affinity for the alpha1D subtype: structural requirements for aporphines at alpha1-adrenoceptor subtypes.
    Ivorra MD, Valiente M, Martínez S, Madrero Y, Noguera MA, Cassels BK, Sobarzo EM, D'Ocon P.
    Planta Med; 2005 Oct; 71(10):897-903. PubMed ID: 16254819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.